InsiderClue
Stocks · Health care · Pharmaceutical Preparations

Arcus Biosciences, Inc.

RCUS Clue Score25
United States Fiscal year ends December CIK 0001724521
$24.41 +2.43% Close, 9 Oct 2026
Alert on the numbers Alert on insider trades
Price $24.41 −23.38% Close, 9 Oct 2026

Closing prices at the end of each trading day, from 15 Mar 2018. Not a live quote. Adjusted for share splits, so the line has no step at a split; dividends are not added back. P/E and P/FCF are the market value over the last full fiscal year's net income or free cash flow, as public on each day, so they step once a year when the annual report comes out. A hatched band marks a stretch with none: a year of net loss, or of cash burnt.

Revenue and profit

What the business sells, and what is left of it. Point at a year for the detail.
RevenueOperating incomeNet income
Fiscal year 2016Operating income−18.2Net income−18.0Fiscal year 2017Revenue1.4Operating income−53.4Net income−53.1Fiscal year 2018Revenue8.4 +491.2%Operating income−54.9Net income−49.6Fiscal year 2019Revenue15.0 +79.6%Operating income−88.7Net income−84.7EPS, diluted−1.93Fiscal year 2020Revenue78.0 +420.0%Operating income−124.0Net income−123.0EPS, diluted−2.24Fiscal year 2021Revenue383.0 +391.0%Operating income54.0Net income53.0EPS, diluted0.71Fiscal year 2022Revenue38.0 −90.1%Operating income−280.0Net income−267.0 −603.8%EPS, diluted−3.71 −622.5%Fiscal year 2023Revenue37.0 −2.6%Operating income−340.0Net income−307.0EPS, diluted−4.15Fiscal year 2024Revenue51.0 +37.8%Operating income−330.0Net income−283.0EPS, diluted−3.14Fiscal year 2025Revenue33.0 −35.3%Operating income−386.0Net income−353.0EPS, diluted−3.29
FY2016FY2017FY2018FY2019FY2020FY2021FY2022FY2023FY2024FY2025
Revenue n/a 1.4 8.4 15.0 78.0 383.0 38.0 37.0 51.0 33.0
Growth +491.2% +79.6% +420.0% +391.0% −90.1% −2.6% +37.8% −35.3%
Operating income −18.2 −53.4 −54.9 −88.7 −124.0 54.0 −280.0 −340.0 −330.0 −386.0
Net income −18.0 −53.1 −49.6 −84.7 −123.0 53.0 −267.0 −307.0 −283.0 −353.0
Growth −603.8%
EPS, diluted n/a n/a n/a −1.93 −2.24 0.71 −3.71 −4.15 −3.14 −3.29
Growth −622.5%

Margins

How much of each dollar of revenue it keeps. Point at a year for the detail.
Operating marginNet margin
Fiscal year 2016Fiscal year 2017Operating margin−3,782.1%Net margin−3,756.7%Free cash flow margin−2,163.7%Fiscal year 2018Operating margin−656.8%Net margin−593.7%Free cash flow margin−559.5%Fiscal year 2019Operating margin−591.4%Net margin−564.7%Free cash flow margin−502.6%Fiscal year 2020Operating margin−159.0%Net margin−157.7%Free cash flow margin138.5%Fiscal year 2021Operating margin14.1%Net margin13.8%Free cash flow margin−73.6%Fiscal year 2022Operating margin−736.8%Net margin−702.6%Free cash flow margin1,136.8%Fiscal year 2023Operating margin−918.9%Net margin−829.7%Free cash flow margin−891.9%Fiscal year 2024Operating margin−647.1%Net margin−554.9%Free cash flow margin−345.1%Fiscal year 2025Operating margin−1,169.7%Net margin−1,069.7%Free cash flow margin−1,466.7%
FY2016FY2017FY2018FY2019FY2020FY2021FY2022FY2023FY2024FY2025
Operating margin n/a −3,782.1% −656.8% −591.4% −159.0% 14.1% −736.8% −918.9% −647.1% −1,169.7%
Net margin n/a −3,756.7% −593.7% −564.7% −157.7% 13.8% −702.6% −829.7% −554.9% −1,069.7%
Free cash flow margin n/a −2,163.7% −559.5% −502.6% 138.5% −73.6% 1,136.8% −891.9% −345.1% −1,466.7%

Cash flow

The cash the business makes, what it reinvests, and what it hands back. Point at a year for the detail.
Operating cash flowCapital expenditureFree cash flow
Fiscal year 2016Operating cash flow−12.9Capital expenditure−4.1Free cash flow−17.0Fiscal year 2017Operating cash flow−25.1Capital expenditure−5.5Free cash flow−30.6Fiscal year 2018Operating cash flow−43.0Capital expenditure−3.7Free cash flow−46.7Buybacks0.0Fiscal year 2019Operating cash flow−73.5Capital expenditure−1.9Free cash flow−75.4Buybacks−0.1Fiscal year 2020Operating cash flow111.0Capital expenditure−3.0Free cash flow108.0Fiscal year 2021Operating cash flow−256.0Capital expenditure−26.0Free cash flow−282.0 −361.1%Fiscal year 2022Operating cash flow438.0Capital expenditure−6.0Free cash flow432.0Fiscal year 2023Operating cash flow−306.0Capital expenditure−24.0Free cash flow−330.0 −176.4%Fiscal year 2024Operating cash flow−170.0Capital expenditure−6.0Free cash flow−176.0Fiscal year 2025Operating cash flow−482.0Capital expenditure−2.0Free cash flow−484.0
FY2016FY2017FY2018FY2019FY2020FY2021FY2022FY2023FY2024FY2025
Operating cash flow −12.9 −25.1 −43.0 −73.5 111.0 −256.0 438.0 −306.0 −170.0 −482.0
Capital expenditure −4.1 −5.5 −3.7 −1.9 −3.0 −26.0 −6.0 −24.0 −6.0 −2.0
Free cash flow −17.0 −30.6 −46.7 −75.4 108.0 −282.0 432.0 −330.0 −176.0 −484.0
Growth −361.1% −176.4%
Buybacks n/a n/a 0.0 −0.1 n/a n/a n/a n/a n/a n/a

Balance sheet

What it holds against what it owes, at each year end. Point at a year for the detail.
CashTotal debt
Fiscal year 2016Cash65.2Shareholders’ equity−20.0Fiscal year 2017Cash98.4Shareholders’ equity−72.3Fiscal year 2018Cash71.1Shareholders’ equity234.9Fiscal year 2019Cash57.9Shareholders’ equity164.0Fiscal year 2020Cash173.4Shareholders’ equity502.0Fiscal year 2021Cash148.0Shareholders’ equity842.0Fiscal year 2022Cash206.0Shareholders’ equity657.0Fiscal year 2023Cash127.0Total debt0.0Net cash (debt)127.0Shareholders’ equity462.0Debt to equity0.00Fiscal year 2024Cash150.0Total debt48.0Net cash (debt)102.0Shareholders’ equity485.0Debt to equity0.10Fiscal year 2025Cash222.0Total debt99.0Net cash (debt)123.0Shareholders’ equity631.0Debt to equity0.16
FY2016FY2017FY2018FY2019FY2020FY2021FY2022FY2023FY2024FY2025
Cash 65.2 98.4 71.1 57.9 173.4 148.0 206.0 127.0 150.0 222.0
Total debt n/a n/a n/a n/a n/a n/a n/a 0.0 48.0 99.0
Net cash (debt) n/a n/a n/a n/a n/a n/a n/a 127.0 102.0 123.0
Shareholders’ equity −20.0 −72.3 234.9 164.0 502.0 842.0 657.0 462.0 485.0 631.0
Debt to equity n/a n/a n/a n/a n/a n/a n/a 0.00 0.10 0.16

In millions of USD, except per-share figures and ratios. Fiscal years, as last filed with the SEC.

Financial statements FY2025 · 10-K

Cash flow

In millions of USD, except per-share figures; shares in millions. Fiscal years ending December, each column as last filed with the SEC.
Click a line to chart it
Fiscal year FY2016 31 Dec 2016 FY2017 31 Dec 2017 FY2018 31 Dec 2018 FY2019 31 Dec 2019 FY2020 31 Dec 2020 FY2021 31 Dec 2021 FY2022 31 Dec 2022 FY2023 31 Dec 2023 FY2024 31 Dec 2024 FY2025 31 Dec 2025
Operations
−12.9 −25.1 −43.0 −73.5 111.0 −256.0 438.0 −306.0 −170.0 −482.0
Growth −330.6% −169.9%
Investment
−4.1 −5.5 −3.7 −1.9 −3.0 −26.0 −6.0 −24.0 −6.0 −2.0
calc −17.0 −30.6 −46.7 −75.4 108.0 −282.0 432.0 −330.0 −176.0 −484.0
Growth −361.1% −176.4%
calc n/a n/a n/a −1.72 1.97 −3.81 6.00 −4.46 −1.95 −4.51
−38.9 −49.1 −113.4 59.2 −434.0 −4.0 −413.0 194.0 −84.0 66.0
Financing
70.1 107.4 129.1 1.1 439.0 237.0 33.0 33.0 277.0 488.0
n/a n/a 0.0 −0.1 n/a n/a n/a n/a n/a n/a

Lines marked calc are worked out here from filed figures; point at one for how. Capital expenditure, dividends and buybacks are shown as money out, so negative.